Biomea Fusion, Inc. (BMEA)
USD 1.95
(-9.72%)
USD 1.95
(-9.72%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -96.59 Million | -62.41 Million | -35.43 Million | -4.45 Million | -1.27 Million |
| Net Income | -117.25 Million | -81.82 Million | -41.56 Million | -5.32 Million | -1.19 Million |
| Depreciation & Amortization | 4.2 Million | 691 Thousand | 249 Thousand | 8000.00 | - |
| Deferred income taxes | - | - | 516 Thousand | - | - |
| Stock-based compensation | 14.13 Million | 10.33 Million | 6.23 Million | 322 Thousand | - |
| Change in working capital | 2.33 Million | 7.66 Million | -1.57 Million | 411 Thousand | -81 Thousand |
| Other non-cash items | 19.97 Million | 715 Thousand | 704 Thousand | 124 Thousand | 98 Thousand |
| Investing Cash Flow | -2.22 Million | 27.34 Million | -33.35 Million | -51 Thousand | - |
| Investments in PPE | -3.37 Million | -1.03 Million | -3.17 Million | -51 Thousand | - |
| Acquisitions | - | - | 30.18 Thousand | - | - |
| Investment purchases | - | - | -38.49 Million | - | - |
| Sales/Maturities of investments | 1.15 Million | 28.37 Million | 8.3 Million | - | - |
| Other Investing Activities | 1.15 Million | 28.37 Million | -30.18 Thousand | - | - |
| Financing Cash Flow | 163.79 Million | 1.23 Million | 153.18 Million | 65.96 Million | 1.44 Million |
| Debt repayment | - | - | -36 Thousand | -36 Thousand | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 163.79 Million | 1.23 Million | 152.75 Million | 10.19 Million | 1.44 Million |
| Other Financing Activities | 163.79 Million | 1.23 Million | 468 Thousand | 55.81 Million | 1.44 Million |
| Accounts receivables | - | - | - | - | - |
| Accounts payables | 2.56 Million | 2.96 Million | 640 Thousand | 418 Thousand | -98 Thousand |
| Inventory | - | - | - | - | - |
| Other working capital | -232 Thousand | 4.7 Million | -2.21 Million | -7000.00 | 17 Thousand |
| Cash at beginning of period | 111.89 Million | 146.08 Million | 61.69 Million | 239 Thousand | 78 Thousand |
| Cash at end of period | 176.86 Million | 112.25 Million | 146.08 Million | 61.69 Million | 239 Thousand |
| Capital Expenditure | -3.37 Million | -1.03 Million | -3.17 Million | -51 Thousand | - |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | 64.96 Million | -33.83 Million | 84.39 Million | 61.45 Million | 161 Thousand |
| Free Cash Flow | -99.96 Million | -63.44 Million | -38.6 Million | -4.51 Million | -1.27 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -32.78 Million | -37.27 Million | -39.06 Million | -34.88 Million | -117.25 Million | -28.42 Million |
| Depreciation & Amortization | 459 Thousand | 400 Thousand | 420 Thousand | 1.13 Million | 4.2 Million | 419 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 4.74 Million | 4.84 Million | 5.02 Million | 3.86 Million | 14.13 Million | 3.59 Million |
| Change in working capital | 416.99 Thousand | -1 Million | 590 Thousand | 7.05 Million | 2.33 Million | -178 Thousand |
| Other non-cash items | 1.95 Million | 4.92 Million | 9.03 Million | 2.46 Million | 19.97 Million | 691 Thousand |
| Investing Cash Flow | -186 Thousand | -59 Thousand | -35 Thousand | -8000.00 | -2.22 Million | -39 Thousand |
| Investments in PPE | -186 Thousand | -59 Thousand | -35 Thousand | -8000.00 | -3.37 Million | -39 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | 1.15 Million | - |
| Other Investing Activities | - | - | - | - | 1.15 Million | - |
| Financing Cash Flow | 69 Thousand | 1.07 Million | 116 Thousand | 622 Thousand | 163.79 Million | 138 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | -1.18 Million | 1.07 Million | 116 Thousand | 622 Thousand | 163.79 Million | 138 Thousand |
| Other Financing Activities | 1.25 Million | 1.07 Million | 116 Thousand | 622 Thousand | 163.79 Million | 138 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 3.12 Million | 1.11 Million | -2.17 Million | 3.66 Million | 2.56 Million | -936 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -641 Thousand | -2.12 Million | 2.76 Million | 3.39 Million | -232 Thousand | 758 Thousand |
| Cash at beginning of period | 113.28 Million | 144.91 Million | 176.86 Million | 199.09 Million | 111.89 Million | 223.25 Million |
| Cash at end of period | 88.32 Million | 113.28 Million | 144.91 Million | 176.86 Million | 176.86 Million | 199.45 Million |
| Capital Expenditure | -186 Thousand | -59 Thousand | -35 Thousand | -8000.00 | -3.37 Million | -39 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -24.96 Million | -31.63 Million | -31.94 Million | -22.22 Million | 64.96 Million | -23.8 Million |
| Free Cash Flow | -25.4 Million | -32.7 Million | -32.06 Million | -22.84 Million | -99.96 Million | -23.93 Million |
RRX
TRT
KNSA
SCM
1682
FFIV